NYSE:INSP Inspire Medical Systems (INSP) Stock Price, News & Analysis → Trump’s “Tax Free” Retirement Strategy (From Gold Safe Exchange) (Ad) Free INSP Stock Alerts $215.02 +1.52 (+0.71%) (As of 03/28/2024 ET) Add Compare Share Share Today's Range$214.00▼$223.4050-Day Range$177.50▼$226.0052-Week Range$123.27▼$330.00Volume614,184 shsAverage Volume521,464 shsMarket Capitalization$6.52 billionP/E RatioN/ADividend YieldN/APrice Target$271.29 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability Get Inspire Medical Systems alerts: Email Address Inspire Medical Systems MarketRank™ Stock AnalysisAnalyst RatingModerate Buy2.69 Rating ScoreUpside/Downside26.3% Upside$271.29 Price TargetShort InterestBearish6.17% of Shares Sold ShortDividend StrengthN/ASustainability-0.66Upright™ Environmental ScoreNews Sentiment0.70Based on 14 Articles This WeekInsider TradingSelling Shares$4 M Sold Last QuarterProj. Earnings GrowthGrowingFrom ($0.35) to $0.58 Per ShareSee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.4.71 out of 5 starsMedical Sector56th out of 938 stocksSurgical & Medical Instruments Industry10th out of 97 stocks 4.3 Analyst's Opinion Consensus RatingInspire Medical Systems has received a consensus rating of Moderate Buy. The company's average rating score is 2.69, and is based on 9 buy ratings, 4 hold ratings, and no sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of $271.29, Inspire Medical Systems has a forecasted upside of 26.3% from its current price of $214.79.Amount of Analyst CoverageInspire Medical Systems has been the subject of 6 research reports in the past 90 days, demonstrating strong analyst interest in this stock. Previous Next 2.0 Short Interest Percentage of Shares Shorted6.17% of the outstanding shares of Inspire Medical Systems have been sold short.Short Interest Ratio / Days to CoverInspire Medical Systems has a short interest ratio ("days to cover") of 3.7, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Inspire Medical Systems has recently increased by 6.86%, indicating that investor sentiment is decreasing significantly. Previous Next 0.0 Dividend Strength Dividend YieldInspire Medical Systems does not currently pay a dividend.Dividend GrowthInspire Medical Systems does not have a long track record of dividend growth. Previous Next 4.8 Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreInspire Medical Systems has received a 78.27% net impact score from Upright. The largest positive contribution comes from its "Physical diseases" impact, which is false driven by its "Neurostimulators" and "Medical technology engineering" products. See details.Environmental SustainabilityThe Environmental Impact score for Inspire Medical Systems is -0.66. Previous Next 2.6 News and Social Media Coverage News SentimentInspire Medical Systems has a news sentiment score of 0.70. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Medical companies.News Coverage This WeekMarketBeat has tracked 14 news articles for Inspire Medical Systems this week, compared to 7 articles on an average week.Search InterestOnly 8 people have searched for INSP on MarketBeat in the last 30 days. This is a decrease of -33% compared to the previous 30 days.MarketBeat Follows8 people have added Inspire Medical Systems to their MarketBeat watchlist in the last 30 days. Previous Next 2.5 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Inspire Medical Systems insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $4,003,381.00 in company stock.Percentage Held by InsidersOnly 4.10% of the stock of Inspire Medical Systems is held by insiders.Percentage Held by Institutions94.91% of the stock of Inspire Medical Systems is held by institutions. High institutional ownership can be a signal of strong market trust in this company. Previous Next 0.6 Earnings and Valuation Earnings GrowthEarnings for Inspire Medical Systems are expected to grow in the coming year, from ($0.35) to $0.58 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Inspire Medical Systems is -290.26, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Inspire Medical Systems is -290.26, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioInspire Medical Systems has a P/B Ratio of 11.08. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here Ad Gold Safe ExchangeTrump’s “Tax Free” Retirement Strategy Since 1924 — over one hundred years — the US dollar has lost nearly 18x its value. In other words, a dollar back then would buy $17.82 worth of goods in today's money. If you're planning on retiring any time soon…This poses a real problem.Protect your retirement savings from the inevitable devaluation of the dollar… About Inspire Medical Systems Stock (NYSE:INSP)Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA. It also develops a novel, closed-loop solution that continuously monitors a patient's breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. The company was incorporated in 2007 and is headquartered in Golden Valley, Minnesota.Read More INSP Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart INSP Stock News HeadlinesMarch 28, 2024 | insidertrades.comJerry C. Griffin Sells 554 Shares of Inspire Medical Systems, Inc. (NYSE:INSP) StockMarch 27, 2024 | insidertrades.comInspire Medical Systems, Inc. (NYSE:INSP) CTO Sells $852,832.80 in StockMarch 28, 2024 | Gold Safe Exchange (Ad)Trump’s “Tax Free” Retirement Strategy Since 1924 — over one hundred years — the US dollar has lost nearly 18x its value. In other words, a dollar back then would buy $17.82 worth of goods in today's money. If you're planning on retiring any time soon…This poses a real problem.March 21, 2024 | insidertrades.comInspire Medical Systems, Inc. (NYSE:INSP) Director Sells $107,215.62 in StockMarch 28, 2024 | msn.comPopular Indian blogger who lost stomach to cancer dies at 50March 28, 2024 | cbsnews.comWomen leading the way at Doral healthcare construction siteMarch 28, 2024 | americanbankingnews.comInspire Medical Systems (NYSE:INSP) Given Buy Rating at MizuhoMarch 27, 2024 | americanbankingnews.comInspire Medical Systems, Inc. (NYSE:INSP) CTO John Rondoni Sells 4,387 Shares of StockMarch 28, 2024 | Gold Safe Exchange (Ad)Trump’s “Tax Free” Retirement Strategy Since 1924 — over one hundred years — the US dollar has lost nearly 18x its value. In other words, a dollar back then would buy $17.82 worth of goods in today's money. If you're planning on retiring any time soon…This poses a real problem.March 21, 2024 | markets.businessinsider.comLeerink Partners Remains a Hold on Inspire Medical Systems (INSP)March 21, 2024 | americanbankingnews.comInspire Medical Systems (NYSE:INSP) Earns "Buy" Rating from Truist FinancialMarch 21, 2024 | americanbankingnews.comInspire Medical Systems (NYSE:INSP) Earns Overweight Rating from Analysts at Morgan StanleyMarch 20, 2024 | finance.yahoo.comInspire Medical Systems, Inc.'s (NYSE:INSP) Intrinsic Value Is Potentially 35% Above Its Share PriceMarch 20, 2024 | americanbankingnews.comInspire Medical Systems, Inc. (NYSE:INSP) Given Consensus Rating of "Moderate Buy" by BrokeragesMarch 18, 2024 | msn.comInnovative interventions combat mental health impacts of climate changeMarch 16, 2024 | finance.yahoo.comINSP Apr 2024 150.000 callMarch 15, 2024 | tmcnet.comEdifecs to Speak at RISE National 2024March 15, 2024 | markets.businessinsider.comAnalysts Have Conflicting Sentiments on These Healthcare Companies: Madrigal Pharmaceuticals (MDGL), Inspire Medical Systems (INSP) and Cencora (COR)March 14, 2024 | msn.comRacial health disparities focus of Black Maternal Health Equity Summit at CSUMarch 14, 2024 | msn.comGene expression technology set to semi-automationMarch 14, 2024 | finance.yahoo.comDirector Jerry Griffin Sells Shares of Inspire Medical Systems Inc (INSP)March 14, 2024 | msn.com‘Living fossils’ could inspire advancements in human healthMarch 12, 2024 | startribune.comNo waiting line for vets' careMarch 12, 2024 | finance.yahoo.comINSP Jan 2025 185.000 callMarch 12, 2024 | finance.yahoo.comINSP Dec 2024 135.000 putMarch 12, 2024 | msn.comMariner High teens crack congressional coding contest — againMarch 11, 2024 | yahoo.comThe 14 Most Beautiful Botanical Gardens In The SouthSee More Headlines Receive INSP Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Inspire Medical Systems and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings2/06/2024Today3/28/2024Next Earnings (Estimated)5/07/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSE SectorMedical Industry Surgical & medical instruments Sub-IndustryN/A Current SymbolNYSE:INSP CUSIPN/A CIK1609550 Webwww.inspiresleep.com Phone(844) 672-4357FaxN/AEmployees1,011Year FoundedN/APrice Target and Rating Average Stock Price Target$271.29 High Stock Price Target$371.00 Low Stock Price Target$159.00 Potential Upside/Downside+26.2%Consensus RatingModerate Buy Rating Score (0-4)2.69 Research Coverage13 Analysts Profitability EPS (Most Recent Fiscal Year)($0.74) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-21,150,000.00 Net Margins-3.39% Pretax Margin-3.19% Return on Equity-3.93% Return on Assets-3.38% Debt Debt-to-Equity RatioN/A Current Ratio7.60 Quick Ratio7.17 Sales & Book Value Annual Sales$624.80 million Price / Sales10.43 Cash FlowN/A Price / Cash FlowN/A Book Value$19.39 per share Price / Book11.09Miscellaneous Outstanding Shares30,300,000Free Float29,055,000Market Cap$6.52 billion OptionableOptionable Beta1.35 A Guide To High-Short-Interest StocksMarketBeat's analysts have just released their top five short plays for April 2024. Learn which stocks have the most short interest and how to trade them. Click the link below to see which companies made the list.Get This Free Report Key ExecutivesMr. Timothy P. Herbert (Age 60)CEO, President & Director Comp: $1.35MMr. Richard J. Buchholz (Age 55)Chief Financial Officer Comp: $683.2kMr. Philip J. Ebeling (Age 53)Chief Operating Officer Comp: $696.13kMr. John C. Rondoni (Age 44)Chief Technology Officer Comp: $576.72kMr. Randall A. Ban (Age 59)Chief Commercial Officer Comp: $759.23kDr. Charisse Y. Sparks FAAOS (Age 60)M.D., Chief Medical Officer Comp: $21.88kMs. Ezgi YagciVice President of Investor RelationsMr. Bryan K. Phillips (Age 53)Senior VP, General Counsel, Chief Compliance Officer & Corporate Secretary Comp: $639.9kMr. Steven L. Jandrich (Age 57)Vice President of Human Resources Comp: $417.22kMr. Ivan LubogoSenior Vice President of U.S. SalesMore ExecutivesKey CompetitorsGlobus MedicalNYSE:GMEDGlaukosNYSE:GKOSMerit Medical SystemsNASDAQ:MMSIHaemoneticsNYSE:HAEPenumbraNYSE:PENView All CompetitorsInsiders & InstitutionsJerry C GriffinSold 554 sharesTotal: $109,586.74 ($197.81/share)John RondoniSold 4,387 sharesTotal: $852,832.80 ($194.40/share)PNC Financial Services Group Inc.Bought 4,844 shares on 3/22/2024Ownership: 0.025%Jerry C GriffinSold 554 sharesTotal: $107,215.62 ($193.53/share)Vanguard Group Inc.Sold 80,927 shares on 3/11/2024Ownership: 9.910%View All Insider TransactionsView All Institutional Transactions INSP Stock Analysis - Frequently Asked Questions Should I buy or sell Inspire Medical Systems stock right now? 13 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Inspire Medical Systems in the last twelve months. There are currently 4 hold ratings and 9 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "moderate buy" INSP shares. View INSP analyst ratings or view top-rated stocks. What is Inspire Medical Systems' stock price target for 2024? 13 Wall Street research analysts have issued twelve-month price objectives for Inspire Medical Systems' shares. Their INSP share price targets range from $159.00 to $371.00. On average, they predict the company's share price to reach $271.29 in the next year. This suggests a possible upside of 26.3% from the stock's current price. View analysts price targets for INSP or view top-rated stocks among Wall Street analysts. How have INSP shares performed in 2024? Inspire Medical Systems' stock was trading at $203.43 at the start of the year. Since then, INSP shares have increased by 5.6% and is now trading at $214.79. View the best growth stocks for 2024 here. Are investors shorting Inspire Medical Systems? Inspire Medical Systems saw a increase in short interest in March. As of March 15th, there was short interest totaling 1,870,000 shares, an increase of 6.9% from the February 29th total of 1,750,000 shares. Based on an average daily volume of 512,300 shares, the days-to-cover ratio is currently 3.7 days. View Inspire Medical Systems' Short Interest. When is Inspire Medical Systems' next earnings date? The company is scheduled to release its next quarterly earnings announcement on Tuesday, May 7th 2024. View our INSP earnings forecast. How were Inspire Medical Systems' earnings last quarter? Inspire Medical Systems, Inc. (NYSE:INSP) announced its quarterly earnings results on Tuesday, February, 6th. The company reported $0.49 EPS for the quarter, topping analysts' consensus estimates of ($0.04) by $0.53. The business had revenue of $192.51 million for the quarter, compared to the consensus estimate of $186.75 million. Inspire Medical Systems had a negative net margin of 3.39% and a negative trailing twelve-month return on equity of 3.93%. The company's revenue for the quarter was up 39.6% compared to the same quarter last year. During the same period in the prior year, the business earned $0.10 EPS. What ETFs hold Inspire Medical Systems' stock? ETFs with the largest weight of Inspire Medical Systems (NYSE:INSP) stock in their portfolio include Harbor Health Care ETF (MEDI), First Trust Nasdaq Lux Digital Health Solutions ETF (EKG), Fidelity Digital Health ETF (FDHT), Invesco Dorsey Wright Healthcare Momentum ETF (PTH), Fidelity Disruptive Medicine ETF (FMED), BNY Mellon Innovators ETF (BKIV), Principal Healthcare Innovators ETF (BTEC) and Franklin Intelligent Machines ETF (IQM). What guidance has Inspire Medical Systems issued on next quarter's earnings? Inspire Medical Systems issued an update on its FY 2024 earnings guidance on Tuesday, February, 27th. The company provided EPS guidance of for the period. The company issued revenue guidance of $775.0 million-$785.0 million, compared to the consensus revenue estimate of $780.3 million. What is Tim Herbert's approval rating as Inspire Medical Systems' CEO? 2 employees have rated Inspire Medical Systems Chief Executive Officer Tim Herbert on Glassdoor.com. Tim Herbert has an approval rating of 100% among the company's employees. This puts Tim Herbert in the top 10% of approval ratings compared to other CEOs of publicly-traded companies. What other stocks do shareholders of Inspire Medical Systems own? Based on aggregate information from My MarketBeat watchlists, some companies that other Inspire Medical Systems investors own include Advanced Micro Devices (AMD), NVIDIA (NVDA), Cisco Systems (CSCO), Bank of America (BAC), DocuSign (DOCU), Pfizer (PFE), Block (SQ), Zynga (ZNGA), CrowdStrike (CRWD) and Johnson & Johnson (JNJ). When did Inspire Medical Systems IPO? Inspire Medical Systems (INSP) raised $75 million in an initial public offering on Thursday, May 3rd 2018. The company issued 5,000,000 shares at a price of $14.00-$16.00 per share. BofA Merrill Lynch and Goldman Sachs acted as the underwriters for the IPO and Guggenheim Securities, Stifel and Wells Fargo Securities were co-managers. Who are Inspire Medical Systems' major shareholders? Inspire Medical Systems' stock is owned by many different institutional and retail investors. Top institutional investors include Vanguard Group Inc. (9.91%), Vanguard Group Inc. (9.91%), Wellington Management Group LLP (4.84%), Baillie Gifford & Co. (4.17%), Wasatch Advisors LP (3.71%) and Frontier Capital Management Co. LLC (2.51%). Insiders that own company stock include Georgia Melenikiotou, Jerry C Griffin, John Rondoni, Marilyn C Nelson, Philip Ebeling, Randy Ban, Richard Buchholz, Steven Jandrich and Timothy P Herbert. View institutional ownership trends. How do I buy shares of Inspire Medical Systems? Shares of INSP stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NYSE:INSP) was last updated on 3/28/2024 by MarketBeat.com Staff From Our PartnersTrump’s “Tax Free” Retirement Strategy Gold Safe ExchangeGrab Your Free Bitcoin Today!Crypto Swap ProfitsForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill Publishing“The Stock Market’s Bull Run is Far from Over” -BarronsVertical Research AdvisoryFed launches fourth dollar overhaulStansberry ResearchMost important medical advance in 100 yearsThe Oxford ClubThe 3rd Revolution in WarfareWeiss RatingsBuy this small stock before coming AI Tidal WaveChaikin Analytics Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Inspire Medical Systems, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.